NCT03653481View on ClinicalTrials.gov

Treating IBD With Inulin

NACompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

October 29, 2018

Primary Completion Date

June 30, 2022

Study Completion Date

August 30, 2022

Conditions
Inflammatory Bowel Diseases
Interventions
DIETARY_SUPPLEMENT

Oligofructose-enriched Inulin OI

Consumed as a powder, 8g/d for children \<50kg and 16g/d for children ≥50kg, divided in 2 daily doses.

DIETARY_SUPPLEMENT

Maltodextrin

Consumed as a powder, 8g/d for children \<50kg and 16g/d for children ≥50kg, divided in 2 daily doses.

Trial Locations (1)

19146

Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
collaborator

Beneo GmbH

INDUSTRY

lead

Children's Hospital of Philadelphia

OTHER

NCT03653481 - Treating IBD With Inulin | Biotech Hunter | Biotech Hunter